SOCS1 and Hyperglycemia: A recent study described that miRNA-155 deficiency promotes nephrin acetylation and decreases renal damage in hyperglycemia induced nephropathy, effects that were associated with inhibited IL-17A production through enhancement of suppressor of cytokine signaling 1 (SOCS1) expression [116].